nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—PGR—Betamethasone—ankylosing spondylitis	0.114	0.262	CbGbCtD
Norethindrone—PGR—Dexamethasone—ankylosing spondylitis	0.0662	0.152	CbGbCtD
Norethindrone—Danazol—Prednisone—ankylosing spondylitis	0.0368	0.0755	CrCrCtD
Norethindrone—Cortisone acetate—Methylprednisolone—ankylosing spondylitis	0.0339	0.0698	CrCrCtD
Norethindrone—Cortisone acetate—Prednisone—ankylosing spondylitis	0.031	0.0637	CrCrCtD
Norethindrone—Cortisone acetate—Prednisolone—ankylosing spondylitis	0.0302	0.0622	CrCrCtD
Norethindrone—Fluoxymesterone—Dexamethasone—ankylosing spondylitis	0.0298	0.0612	CrCrCtD
Norethindrone—Fluoxymesterone—Betamethasone—ankylosing spondylitis	0.0298	0.0612	CrCrCtD
Norethindrone—Fluoxymesterone—Triamcinolone—ankylosing spondylitis	0.0291	0.0598	CrCrCtD
Norethindrone—Fluoxymesterone—Prednisolone—ankylosing spondylitis	0.027	0.0554	CrCrCtD
Norethindrone—Progesterone—Prednisolone—ankylosing spondylitis	0.0263	0.054	CrCrCtD
Norethindrone—Methyltestosterone—Prednisone—ankylosing spondylitis	0.0262	0.0539	CrCrCtD
Norethindrone—Methyltestosterone—Prednisolone—ankylosing spondylitis	0.0256	0.0526	CrCrCtD
Norethindrone—CYP3A5—Sulfasalazine—ankylosing spondylitis	0.0242	0.0557	CbGbCtD
Norethindrone—ALB—Prednisone—ankylosing spondylitis	0.0241	0.0554	CbGbCtD
Norethindrone—Hydrocortisone—Methylprednisolone—ankylosing spondylitis	0.024	0.0494	CrCrCtD
Norethindrone—Hydrocortisone—Dexamethasone—ankylosing spondylitis	0.0237	0.0487	CrCrCtD
Norethindrone—Hydrocortisone—Betamethasone—ankylosing spondylitis	0.0237	0.0487	CrCrCtD
Norethindrone—Hydrocortisone—Triamcinolone—ankylosing spondylitis	0.0231	0.0475	CrCrCtD
Norethindrone—Testosterone—Prednisolone—ankylosing spondylitis	0.0228	0.0469	CrCrCtD
Norethindrone—Hydrocortisone—Prednisone—ankylosing spondylitis	0.0219	0.0451	CrCrCtD
Norethindrone—Hydrocortisone—Prednisolone—ankylosing spondylitis	0.0214	0.044	CrCrCtD
Norethindrone—ABCB1—Methylprednisolone—ankylosing spondylitis	0.0208	0.0479	CbGbCtD
Norethindrone—CYP3A7—Dexamethasone—ankylosing spondylitis	0.0161	0.0371	CbGbCtD
Norethindrone—CYP3A7-CYP3A51P—Dexamethasone—ankylosing spondylitis	0.0161	0.0371	CbGbCtD
Norethindrone—CYP2C19—Prednisone—ankylosing spondylitis	0.0156	0.0359	CbGbCtD
Norethindrone—ABCB1—Betamethasone—ankylosing spondylitis	0.0135	0.0311	CbGbCtD
Norethindrone—ABCB1—Prednisolone—ankylosing spondylitis	0.0134	0.0307	CbGbCtD
Norethindrone—ABCB1—Prednisone—ankylosing spondylitis	0.0126	0.029	CbGbCtD
Norethindrone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0125	0.0287	CbGbCtD
Norethindrone—CYP3A5—Dexamethasone—ankylosing spondylitis	0.0121	0.0278	CbGbCtD
Norethindrone—ALB—Methotrexate—ankylosing spondylitis	0.0121	0.0278	CbGbCtD
Norethindrone—CYP2C19—Dexamethasone—ankylosing spondylitis	0.00976	0.0224	CbGbCtD
Norethindrone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.00945	0.0217	CbGbCtD
Norethindrone—CYP3A4—Betamethasone—ankylosing spondylitis	0.00811	0.0186	CbGbCtD
Norethindrone—CYP3A4—Prednisolone—ankylosing spondylitis	0.008	0.0184	CbGbCtD
Norethindrone—ABCB1—Dexamethasone—ankylosing spondylitis	0.00787	0.0181	CbGbCtD
Norethindrone—CYP3A4—Prednisone—ankylosing spondylitis	0.00756	0.0174	CbGbCtD
Norethindrone—ABCB1—Methotrexate—ankylosing spondylitis	0.00633	0.0145	CbGbCtD
Norethindrone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.00472	0.0108	CbGbCtD
Norethindrone—Optic neuritis—Prednisolone—ankylosing spondylitis	0.000735	0.00936	CcSEcCtD
Norethindrone—Hirsutism—Triamcinolone—ankylosing spondylitis	0.000715	0.00911	CcSEcCtD
Norethindrone—Hirsutism—Methylprednisolone—ankylosing spondylitis	0.000714	0.00909	CcSEcCtD
Norethindrone—Embolism—Prednisolone—ankylosing spondylitis	0.000704	0.00896	CcSEcCtD
Norethindrone—Blindness—Dexamethasone—ankylosing spondylitis	0.000681	0.00867	CcSEcCtD
Norethindrone—Blindness—Betamethasone—ankylosing spondylitis	0.000681	0.00867	CcSEcCtD
Norethindrone—Menstruation irregular—Betamethasone—ankylosing spondylitis	0.000681	0.00867	CcSEcCtD
Norethindrone—Menstruation irregular—Dexamethasone—ankylosing spondylitis	0.000681	0.00867	CcSEcCtD
Norethindrone—Optic neuritis—Triamcinolone—ankylosing spondylitis	0.000676	0.0086	CcSEcCtD
Norethindrone—Optic neuritis—Methylprednisolone—ankylosing spondylitis	0.000674	0.00858	CcSEcCtD
Norethindrone—Hirsutism—Dexamethasone—ankylosing spondylitis	0.000649	0.00826	CcSEcCtD
Norethindrone—Hirsutism—Betamethasone—ankylosing spondylitis	0.000649	0.00826	CcSEcCtD
Norethindrone—Embolism—Triamcinolone—ankylosing spondylitis	0.000647	0.00824	CcSEcCtD
Norethindrone—Embolism—Methylprednisolone—ankylosing spondylitis	0.000646	0.00823	CcSEcCtD
Norethindrone—Optic neuritis—Betamethasone—ankylosing spondylitis	0.000613	0.00781	CcSEcCtD
Norethindrone—Optic neuritis—Dexamethasone—ankylosing spondylitis	0.000613	0.00781	CcSEcCtD
Norethindrone—Dermatitis atopic—Prednisolone—ankylosing spondylitis	0.000611	0.00777	CcSEcCtD
Norethindrone—Menstruation irregular—Prednisone—ankylosing spondylitis	0.000593	0.00755	CcSEcCtD
Norethindrone—Embolism—Dexamethasone—ankylosing spondylitis	0.000587	0.00748	CcSEcCtD
Norethindrone—Embolism—Betamethasone—ankylosing spondylitis	0.000587	0.00748	CcSEcCtD
Norethindrone—Hirsutism—Prednisone—ankylosing spondylitis	0.000565	0.0072	CcSEcCtD
Norethindrone—Dermatitis atopic—Triamcinolone—ankylosing spondylitis	0.000562	0.00715	CcSEcCtD
Norethindrone—Acne—Prednisolone—ankylosing spondylitis	0.000537	0.00684	CcSEcCtD
Norethindrone—Optic neuritis—Prednisone—ankylosing spondylitis	0.000534	0.0068	CcSEcCtD
Norethindrone—Embolism—Prednisone—ankylosing spondylitis	0.000512	0.00651	CcSEcCtD
Norethindrone—Acne—Triamcinolone—ankylosing spondylitis	0.000494	0.00629	CcSEcCtD
Norethindrone—Acne—Methylprednisolone—ankylosing spondylitis	0.000493	0.00627	CcSEcCtD
Norethindrone—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.000472	0.00601	CcSEcCtD
Norethindrone—Deep vein thrombosis—Methotrexate—ankylosing spondylitis	0.000451	0.00574	CcSEcCtD
Norethindrone—Acne—Dexamethasone—ankylosing spondylitis	0.000448	0.00571	CcSEcCtD
Norethindrone—Acne—Betamethasone—ankylosing spondylitis	0.000448	0.00571	CcSEcCtD
Norethindrone—Dermatitis atopic—Prednisone—ankylosing spondylitis	0.000444	0.00565	CcSEcCtD
Norethindrone—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.000429	0.00546	CcSEcCtD
Norethindrone—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.000429	0.00546	CcSEcCtD
Norethindrone—Embolism—Methotrexate—ankylosing spondylitis	0.000428	0.00544	CcSEcCtD
Norethindrone—Acne—Prednisone—ankylosing spondylitis	0.00039	0.00497	CcSEcCtD
Norethindrone—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.000379	0.00483	CcSEcCtD
Norethindrone—Amenorrhoea—Prednisone—ankylosing spondylitis	0.000374	0.00476	CcSEcCtD
Norethindrone—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.000349	0.00444	CcSEcCtD
Norethindrone—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.000348	0.00443	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.000339	0.00432	CcSEcCtD
Norethindrone—Affect lability—Prednisolone—ankylosing spondylitis	0.000323	0.00411	CcSEcCtD
Norethindrone—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.000316	0.00403	CcSEcCtD
Norethindrone—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.000316	0.00403	CcSEcCtD
Norethindrone—Purpura—Triamcinolone—ankylosing spondylitis	0.000313	0.00399	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.000312	0.00397	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.000311	0.00396	CcSEcCtD
Norethindrone—Mood swings—Prednisolone—ankylosing spondylitis	0.000311	0.00396	CcSEcCtD
Norethindrone—Affect lability—Triamcinolone—ankylosing spondylitis	0.000297	0.00378	CcSEcCtD
Norethindrone—Affect lability—Methylprednisolone—ankylosing spondylitis	0.000296	0.00377	CcSEcCtD
Norethindrone—Mood swings—Triamcinolone—ankylosing spondylitis	0.000286	0.00364	CcSEcCtD
Norethindrone—Abdominal distension—Prednisolone—ankylosing spondylitis	0.000285	0.00363	CcSEcCtD
Norethindrone—Mood swings—Methylprednisolone—ankylosing spondylitis	0.000285	0.00363	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000283	0.0036	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000283	0.0036	CcSEcCtD
Norethindrone—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.000275	0.00351	CcSEcCtD
Norethindrone—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.000274	0.00349	CcSEcCtD
Norethindrone—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.000272	0.00346	CcSEcCtD
Norethindrone—Affect lability—Betamethasone—ankylosing spondylitis	0.000269	0.00343	CcSEcCtD
Norethindrone—Affect lability—Dexamethasone—ankylosing spondylitis	0.000269	0.00343	CcSEcCtD
Norethindrone—Migraine—Dexamethasone—ankylosing spondylitis	0.000269	0.00343	CcSEcCtD
Norethindrone—Migraine—Betamethasone—ankylosing spondylitis	0.000269	0.00343	CcSEcCtD
Norethindrone—Abdominal distension—Triamcinolone—ankylosing spondylitis	0.000263	0.00334	CcSEcCtD
Norethindrone—Abdominal distension—Methylprednisolone—ankylosing spondylitis	0.000262	0.00333	CcSEcCtD
Norethindrone—Mood swings—Dexamethasone—ankylosing spondylitis	0.000259	0.0033	CcSEcCtD
Norethindrone—Mood swings—Betamethasone—ankylosing spondylitis	0.000259	0.0033	CcSEcCtD
Norethindrone—Weight increased—Prednisolone—ankylosing spondylitis	0.000258	0.00329	CcSEcCtD
Norethindrone—Acute coronary syndrome—Prednisolone—ankylosing spondylitis	0.000249	0.00317	CcSEcCtD
Norethindrone—Myocardial infarction—Prednisolone—ankylosing spondylitis	0.000248	0.00316	CcSEcCtD
Norethindrone—Purpura—Prednisone—ankylosing spondylitis	0.000247	0.00315	CcSEcCtD
Norethindrone—Weight increased—Triamcinolone—ankylosing spondylitis	0.000237	0.00302	CcSEcCtD
Norethindrone—Weight increased—Methylprednisolone—ankylosing spondylitis	0.000237	0.00301	CcSEcCtD
Norethindrone—Affect lability—Prednisone—ankylosing spondylitis	0.000235	0.00299	CcSEcCtD
Norethindrone—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.00023	0.00293	CcSEcCtD
Norethindrone—Acute coronary syndrome—Triamcinolone—ankylosing spondylitis	0.000229	0.00292	CcSEcCtD
Norethindrone—Acute coronary syndrome—Methylprednisolone—ankylosing spondylitis	0.000229	0.00291	CcSEcCtD
Norethindrone—Haemoglobin—Prednisolone—ankylosing spondylitis	0.000228	0.0029	CcSEcCtD
Norethindrone—Myocardial infarction—Triamcinolone—ankylosing spondylitis	0.000228	0.0029	CcSEcCtD
Norethindrone—Myocardial infarction—Methylprednisolone—ankylosing spondylitis	0.000227	0.0029	CcSEcCtD
Norethindrone—Haemorrhage—Prednisolone—ankylosing spondylitis	0.000227	0.00289	CcSEcCtD
Norethindrone—Photosensitivity—Methotrexate—ankylosing spondylitis	0.000227	0.00289	CcSEcCtD
Norethindrone—Mood swings—Prednisone—ankylosing spondylitis	0.000226	0.00288	CcSEcCtD
Norethindrone—Weight increased—Betamethasone—ankylosing spondylitis	0.000215	0.00274	CcSEcCtD
Norethindrone—Weight increased—Dexamethasone—ankylosing spondylitis	0.000215	0.00274	CcSEcCtD
Norethindrone—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00021	0.00267	CcSEcCtD
Norethindrone—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.000209	0.00266	CcSEcCtD
Norethindrone—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.000209	0.00266	CcSEcCtD
Norethindrone—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.000208	0.00265	CcSEcCtD
Norethindrone—Acute coronary syndrome—Dexamethasone—ankylosing spondylitis	0.000208	0.00265	CcSEcCtD
Norethindrone—Acute coronary syndrome—Betamethasone—ankylosing spondylitis	0.000208	0.00265	CcSEcCtD
Norethindrone—Abdominal distension—Prednisone—ankylosing spondylitis	0.000207	0.00264	CcSEcCtD
Norethindrone—Myocardial infarction—Betamethasone—ankylosing spondylitis	0.000207	0.00263	CcSEcCtD
Norethindrone—Myocardial infarction—Dexamethasone—ankylosing spondylitis	0.000207	0.00263	CcSEcCtD
Norethindrone—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000206	0.00262	CcSEcCtD
Norethindrone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.000205	0.00261	CcSEcCtD
Norethindrone—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00019	0.00242	CcSEcCtD
Norethindrone—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00019	0.00242	CcSEcCtD
Norethindrone—Haemorrhage—Betamethasone—ankylosing spondylitis	0.000189	0.00241	CcSEcCtD
Norethindrone—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.000189	0.00241	CcSEcCtD
Norethindrone—Mood swings—Methotrexate—ankylosing spondylitis	0.000189	0.0024	CcSEcCtD
Norethindrone—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000188	0.00239	CcSEcCtD
Norethindrone—Weight increased—Prednisone—ankylosing spondylitis	0.000188	0.00239	CcSEcCtD
Norethindrone—Depression—Prednisone—ankylosing spondylitis	0.000183	0.00233	CcSEcCtD
Norethindrone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.000182	0.00232	CcSEcCtD
Norethindrone—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.000181	0.00231	CcSEcCtD
Norethindrone—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00018	0.00229	CcSEcCtD
Norethindrone—Breast disorder—Methotrexate—ankylosing spondylitis	0.00018	0.00229	CcSEcCtD
Norethindrone—Convulsion—Prednisolone—ankylosing spondylitis	0.000171	0.00218	CcSEcCtD
Norethindrone—Alopecia—Betamethasone—ankylosing spondylitis	0.000167	0.00213	CcSEcCtD
Norethindrone—Alopecia—Dexamethasone—ankylosing spondylitis	0.000167	0.00213	CcSEcCtD
Norethindrone—Haemoglobin—Prednisone—ankylosing spondylitis	0.000166	0.00211	CcSEcCtD
Norethindrone—Haemorrhage—Prednisone—ankylosing spondylitis	0.000165	0.0021	CcSEcCtD
Norethindrone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.000162	0.00206	CcSEcCtD
Norethindrone—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000161	0.00205	CcSEcCtD
Norethindrone—Oedema—Prednisolone—ankylosing spondylitis	0.000161	0.00205	CcSEcCtD
Norethindrone—Convulsion—Triamcinolone—ankylosing spondylitis	0.000157	0.002	CcSEcCtD
Norethindrone—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.000157	0.002	CcSEcCtD
Norethindrone—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000157	0.002	CcSEcCtD
Norethindrone—Drowsiness—Methotrexate—ankylosing spondylitis	0.000154	0.00195	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000153	0.00195	CcSEcCtD
Norethindrone—Depression—Methotrexate—ankylosing spondylitis	0.000153	0.00195	CcSEcCtD
Norethindrone—Renal failure—Methotrexate—ankylosing spondylitis	0.000151	0.00192	CcSEcCtD
Norethindrone—Immune system disorder—Prednisone—ankylosing spondylitis	0.000149	0.0019	CcSEcCtD
Norethindrone—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000148	0.00189	CcSEcCtD
Norethindrone—Oedema—Triamcinolone—ankylosing spondylitis	0.000148	0.00189	CcSEcCtD
Norethindrone—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000148	0.00188	CcSEcCtD
Norethindrone—Insomnia—Prednisolone—ankylosing spondylitis	0.000146	0.00186	CcSEcCtD
Norethindrone—Alopecia—Prednisone—ankylosing spondylitis	0.000146	0.00186	CcSEcCtD
Norethindrone—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.000145	0.00185	CcSEcCtD
Norethindrone—Mental disorder—Prednisone—ankylosing spondylitis	0.000144	0.00184	CcSEcCtD
Norethindrone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.000144	0.00183	CcSEcCtD
Norethindrone—Convulsion—Dexamethasone—ankylosing spondylitis	0.000143	0.00182	CcSEcCtD
Norethindrone—Convulsion—Betamethasone—ankylosing spondylitis	0.000143	0.00182	CcSEcCtD
Norethindrone—Haemoglobin—Methotrexate—ankylosing spondylitis	0.000139	0.00176	CcSEcCtD
Norethindrone—Haemorrhage—Methotrexate—ankylosing spondylitis	0.000138	0.00175	CcSEcCtD
Norethindrone—Hepatitis—Methotrexate—ankylosing spondylitis	0.000138	0.00175	CcSEcCtD
Norethindrone—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000135	0.00171	CcSEcCtD
Norethindrone—Oedema—Betamethasone—ankylosing spondylitis	0.000135	0.00171	CcSEcCtD
Norethindrone—Oedema—Dexamethasone—ankylosing spondylitis	0.000135	0.00171	CcSEcCtD
Norethindrone—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000135	0.00171	CcSEcCtD
Norethindrone—Insomnia—Triamcinolone—ankylosing spondylitis	0.000134	0.00171	CcSEcCtD
Norethindrone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.000134	0.0017	CcSEcCtD
Norethindrone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000131	0.00166	CcSEcCtD
Norethindrone—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00013	0.00166	CcSEcCtD
Norethindrone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00013	0.00166	CcSEcCtD
Norethindrone—Urticaria—Prednisolone—ankylosing spondylitis	0.000128	0.00163	CcSEcCtD
Norethindrone—Fatigue—Triamcinolone—ankylosing spondylitis	0.000128	0.00163	CcSEcCtD
Norethindrone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000128	0.00162	CcSEcCtD
Norethindrone—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000124	0.00159	CcSEcCtD
Norethindrone—Convulsion—Prednisone—ankylosing spondylitis	0.000124	0.00158	CcSEcCtD
Norethindrone—Alopecia—Methotrexate—ankylosing spondylitis	0.000122	0.00155	CcSEcCtD
Norethindrone—Insomnia—Dexamethasone—ankylosing spondylitis	0.000122	0.00155	CcSEcCtD
Norethindrone—Insomnia—Betamethasone—ankylosing spondylitis	0.000122	0.00155	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000121	0.00155	CcSEcCtD
Norethindrone—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000121	0.00154	CcSEcCtD
Norethindrone—Mental disorder—Methotrexate—ankylosing spondylitis	0.000121	0.00154	CcSEcCtD
Norethindrone—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000119	0.00151	CcSEcCtD
Norethindrone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000118	0.00151	CcSEcCtD
Norethindrone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000118	0.00151	CcSEcCtD
Norethindrone—Urticaria—Triamcinolone—ankylosing spondylitis	0.000118	0.0015	CcSEcCtD
Norethindrone—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000118	0.0015	CcSEcCtD
Norethindrone—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000117	0.00149	CcSEcCtD
Norethindrone—Oedema—Prednisone—ankylosing spondylitis	0.000117	0.00149	CcSEcCtD
Norethindrone—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000117	0.00149	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000116	0.00148	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000116	0.00148	CcSEcCtD
Norethindrone—Fatigue—Dexamethasone—ankylosing spondylitis	0.000116	0.00148	CcSEcCtD
Norethindrone—Fatigue—Betamethasone—ankylosing spondylitis	0.000116	0.00148	CcSEcCtD
Norethindrone—Skin disorder—Prednisone—ankylosing spondylitis	0.000114	0.00145	CcSEcCtD
Norethindrone—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00011	0.0014	CcSEcCtD
Norethindrone—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00011	0.0014	CcSEcCtD
Norethindrone—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000109	0.00139	CcSEcCtD
Norethindrone—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000109	0.00139	CcSEcCtD
Norethindrone—Urticaria—Dexamethasone—ankylosing spondylitis	0.000107	0.00136	CcSEcCtD
Norethindrone—Urticaria—Betamethasone—ankylosing spondylitis	0.000107	0.00136	CcSEcCtD
Norethindrone—Dizziness—Prednisolone—ankylosing spondylitis	0.000107	0.00136	CcSEcCtD
Norethindrone—Asthenia—Triamcinolone—ankylosing spondylitis	0.000106	0.00135	CcSEcCtD
Norethindrone—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000106	0.00135	CcSEcCtD
Norethindrone—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000106	0.00135	CcSEcCtD
Norethindrone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000106	0.00135	CcSEcCtD
Norethindrone—Insomnia—Prednisone—ankylosing spondylitis	0.000106	0.00135	CcSEcCtD
Norethindrone—Pruritus—Triamcinolone—ankylosing spondylitis	0.000105	0.00134	CcSEcCtD
Norethindrone—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000105	0.00133	CcSEcCtD
Norethindrone—Convulsion—Methotrexate—ankylosing spondylitis	0.000104	0.00132	CcSEcCtD
Norethindrone—Dyspepsia—Prednisone—ankylosing spondylitis	0.000103	0.00131	CcSEcCtD
Norethindrone—Rash—Prednisolone—ankylosing spondylitis	0.000102	0.00129	CcSEcCtD
Norethindrone—Dermatitis—Prednisolone—ankylosing spondylitis	0.000102	0.00129	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000101	0.00129	CcSEcCtD
Norethindrone—Fatigue—Prednisone—ankylosing spondylitis	0.000101	0.00129	CcSEcCtD
Norethindrone—Headache—Prednisolone—ankylosing spondylitis	0.000101	0.00129	CcSEcCtD
Norethindrone—Dizziness—Triamcinolone—ankylosing spondylitis	9.81e-05	0.00125	CcSEcCtD
Norethindrone—Anaphylactic shock—Methotrexate—ankylosing spondylitis	9.79e-05	0.00125	CcSEcCtD
Norethindrone—Dizziness—Methylprednisolone—ankylosing spondylitis	9.78e-05	0.00125	CcSEcCtD
Norethindrone—Asthenia—Betamethasone—ankylosing spondylitis	9.65e-05	0.00123	CcSEcCtD
Norethindrone—Asthenia—Dexamethasone—ankylosing spondylitis	9.65e-05	0.00123	CcSEcCtD
Norethindrone—Gastrointestinal pain—Prednisone—ankylosing spondylitis	9.58e-05	0.00122	CcSEcCtD
Norethindrone—Nausea—Prednisolone—ankylosing spondylitis	9.58e-05	0.00122	CcSEcCtD
Norethindrone—Pruritus—Betamethasone—ankylosing spondylitis	9.52e-05	0.00121	CcSEcCtD
Norethindrone—Pruritus—Dexamethasone—ankylosing spondylitis	9.52e-05	0.00121	CcSEcCtD
Norethindrone—Skin disorder—Methotrexate—ankylosing spondylitis	9.51e-05	0.00121	CcSEcCtD
Norethindrone—Vomiting—Triamcinolone—ankylosing spondylitis	9.43e-05	0.0012	CcSEcCtD
Norethindrone—Vomiting—Methylprednisolone—ankylosing spondylitis	9.41e-05	0.0012	CcSEcCtD
Norethindrone—Rash—Triamcinolone—ankylosing spondylitis	9.35e-05	0.00119	CcSEcCtD
Norethindrone—Dermatitis—Triamcinolone—ankylosing spondylitis	9.34e-05	0.00119	CcSEcCtD
Norethindrone—Rash—Methylprednisolone—ankylosing spondylitis	9.33e-05	0.00119	CcSEcCtD
Norethindrone—Dermatitis—Methylprednisolone—ankylosing spondylitis	9.32e-05	0.00119	CcSEcCtD
Norethindrone—Urticaria—Prednisone—ankylosing spondylitis	9.31e-05	0.00119	CcSEcCtD
Norethindrone—Headache—Triamcinolone—ankylosing spondylitis	9.29e-05	0.00118	CcSEcCtD
Norethindrone—Headache—Methylprednisolone—ankylosing spondylitis	9.27e-05	0.00118	CcSEcCtD
Norethindrone—Abdominal pain—Prednisone—ankylosing spondylitis	9.26e-05	0.00118	CcSEcCtD
Norethindrone—Dizziness—Betamethasone—ankylosing spondylitis	8.9e-05	0.00113	CcSEcCtD
Norethindrone—Dizziness—Dexamethasone—ankylosing spondylitis	8.9e-05	0.00113	CcSEcCtD
Norethindrone—Insomnia—Methotrexate—ankylosing spondylitis	8.86e-05	0.00113	CcSEcCtD
Norethindrone—Nausea—Triamcinolone—ankylosing spondylitis	8.81e-05	0.00112	CcSEcCtD
Norethindrone—Nausea—Methylprednisolone—ankylosing spondylitis	8.79e-05	0.00112	CcSEcCtD
Norethindrone—Somnolence—Methotrexate—ankylosing spondylitis	8.71e-05	0.00111	CcSEcCtD
Norethindrone—Hypersensitivity—Prednisone—ankylosing spondylitis	8.63e-05	0.0011	CcSEcCtD
Norethindrone—Dyspepsia—Methotrexate—ankylosing spondylitis	8.62e-05	0.0011	CcSEcCtD
Norethindrone—Vomiting—Dexamethasone—ankylosing spondylitis	8.55e-05	0.00109	CcSEcCtD
Norethindrone—Vomiting—Betamethasone—ankylosing spondylitis	8.55e-05	0.00109	CcSEcCtD
Norethindrone—Rash—Dexamethasone—ankylosing spondylitis	8.48e-05	0.00108	CcSEcCtD
Norethindrone—Rash—Betamethasone—ankylosing spondylitis	8.48e-05	0.00108	CcSEcCtD
Norethindrone—Dermatitis—Dexamethasone—ankylosing spondylitis	8.48e-05	0.00108	CcSEcCtD
Norethindrone—Dermatitis—Betamethasone—ankylosing spondylitis	8.48e-05	0.00108	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	8.45e-05	0.00108	CcSEcCtD
Norethindrone—Fatigue—Methotrexate—ankylosing spondylitis	8.44e-05	0.00107	CcSEcCtD
Norethindrone—Headache—Dexamethasone—ankylosing spondylitis	8.43e-05	0.00107	CcSEcCtD
Norethindrone—Headache—Betamethasone—ankylosing spondylitis	8.43e-05	0.00107	CcSEcCtD
Norethindrone—Asthenia—Prednisone—ankylosing spondylitis	8.41e-05	0.00107	CcSEcCtD
Norethindrone—Pruritus—Prednisone—ankylosing spondylitis	8.29e-05	0.00106	CcSEcCtD
Norethindrone—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	8.01e-05	0.00102	CcSEcCtD
Norethindrone—Nausea—Betamethasone—ankylosing spondylitis	7.99e-05	0.00102	CcSEcCtD
Norethindrone—Nausea—Dexamethasone—ankylosing spondylitis	7.99e-05	0.00102	CcSEcCtD
Norethindrone—Urticaria—Methotrexate—ankylosing spondylitis	7.78e-05	0.00099	CcSEcCtD
Norethindrone—Dizziness—Prednisone—ankylosing spondylitis	7.75e-05	0.000987	CcSEcCtD
Norethindrone—Abdominal pain—Methotrexate—ankylosing spondylitis	7.74e-05	0.000986	CcSEcCtD
Norethindrone—Vomiting—Prednisone—ankylosing spondylitis	7.45e-05	0.000949	CcSEcCtD
Norethindrone—Rash—Prednisone—ankylosing spondylitis	7.39e-05	0.000941	CcSEcCtD
Norethindrone—Dermatitis—Prednisone—ankylosing spondylitis	7.38e-05	0.00094	CcSEcCtD
Norethindrone—Headache—Prednisone—ankylosing spondylitis	7.34e-05	0.000935	CcSEcCtD
Norethindrone—Hypersensitivity—Methotrexate—ankylosing spondylitis	7.21e-05	0.000919	CcSEcCtD
Norethindrone—Asthenia—Methotrexate—ankylosing spondylitis	7.03e-05	0.000895	CcSEcCtD
Norethindrone—Nausea—Prednisone—ankylosing spondylitis	6.96e-05	0.000886	CcSEcCtD
Norethindrone—Pruritus—Methotrexate—ankylosing spondylitis	6.93e-05	0.000882	CcSEcCtD
Norethindrone—Dizziness—Methotrexate—ankylosing spondylitis	6.48e-05	0.000824	CcSEcCtD
Norethindrone—Vomiting—Methotrexate—ankylosing spondylitis	6.23e-05	0.000793	CcSEcCtD
Norethindrone—Rash—Methotrexate—ankylosing spondylitis	6.17e-05	0.000786	CcSEcCtD
Norethindrone—Dermatitis—Methotrexate—ankylosing spondylitis	6.17e-05	0.000785	CcSEcCtD
Norethindrone—Headache—Methotrexate—ankylosing spondylitis	6.13e-05	0.000781	CcSEcCtD
Norethindrone—Nausea—Methotrexate—ankylosing spondylitis	5.82e-05	0.000741	CcSEcCtD
